Faron Pharmaceuticals Oy (DI) (FARN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 40.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 246.97
  • 52 Week Low: 39.00
  • Currency: UK Pounds
  • Shares Issued: 224.35m
  • Volume: 19,893
  • Market Cap: £90.86m

Latest ShareCast News

Inside Information: Faron publishes the terms and conditions of a fully covered rights offering of approximately EUR 40 million and updates cash runway

By Sharecast

Date: Tuesday 10 Mar 2026

Faron Pharmaceuticals Ltd | Company announcement | March 10, 2026 at 09:48:00 EET

Director dealings: Victoria non-exec invests, Faron Pharma CFO sells entire holding

By Josh White

Date: Tuesday 13 Jan 2026

(Sharecast News) - Shares in Victoria saw director support on Tuesday, after the group disclosed that non-executive director Steve Callaghan purchased 260,000 ordinary shares at 37.93p each on 9 January.

Faron issuing second tranche of unsecured convertible bonds

By Josh White

Date: Thursday 11 Dec 2025

(Sharecast News) - Faron Pharmaceuticals said on Thursday that its board had approved the issue of the second tranche of its amortising senior unsecured convertible bonds to an entity managed by Heights Capital Management, raising €10m to extend its cash runway and strengthen its financial position ahead of a planned registrational study in high-risk myelodysplastic syndromes.

Faron Pharmaceuticals appoints new finance chief 01-Dec-2025 ShareCast
Faron strengthens bexmarilimab potential with fr... 20-Oct-2025 ShareCast
Faron narrows first-half losses as it advances i... 27-Aug-2025 ShareCast
Faron secures FDA pathway for lead cancer therapy 18-Aug-2025 ShareCast
Faron Pharmaceuticals appoints chief business of... 21-May-2025 ShareCast
Faron enters financing arrangement with Heights ... 03-Apr-2025 ShareCast
Faron identifies final patient in BEXMAB phase t... 31-Jan-2025 ShareCast
Faron Pharmaceuticals reports regulatory progres... 02-Dec-2024 ShareCast
Faron announces promising MDS trial results 27-Nov-2024 ShareCast
Faron Pharmaceuticals files new patent for Cleve... 11-Nov-2024 ShareCast
Faron Pharmaceuticals candidate gets FDA fast tr... 27-Aug-2024 ShareCast
Faron gets positive FDA feedback on bexmarilimab... 11-Jul-2024 ShareCast
Faron Pharmaceuticals extends funding agreement ... 30-Apr-2024 ShareCast
Faron Pharmaceuticals CFO stands down 15-Apr-2024 ShareCast
Faron Pharmaceuticals taps Juho Jalkanen for CEO 08-Apr-2024 ShareCast
Faron shares jump on encouraging trial data 18-Mar-2024 ShareCast
Faron Pharmaceuticals reports year of clinical p... 13-Mar-2024 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

FARN Market Data

Currency UK Pounds
Share Price 40.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 246.97
52 Week Low 39.00
Volume 19,893
Shares Issued 224.35m
Market Cap £90.86m

FARN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
41.46% below the sector average41.46% below the sector average41.46% below the sector average41.46% below the sector average41.46% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average
Income Not Available
Growth Not Available

FARN Dividends

No dividends found

Trades for 20-Aug-2026

Time Volume / Share Price
14:45 339 @ 41.40p
13:43 3,600 @ 41.40p
12:29 5,000 @ 39.47p
10:33 800 @ 42.00p
10:03 428 @ 42.00p

FARN Key Personnel

CEO Juho Jalkanen
Chair Tuomo Pätsi
CFO Jurriaan Dekkers

Top of Page